This Week in PLOS

Mutations in the RNA-splicing gene SRSF1 prompt the progression of some small-cell lung cancer cases in individuals of Chinese ancestry, according to a PLOS Genetics study. When they sequenced the protein-coding and transcriptome sequences of primary tumors from 99 individuals with small-cell lung cancer, researchers from China and the US saw altered regulation and/or mutations of known tumor suppressor gene such as TP53 and RB1 in the majority of cases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.